ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,687 Cr | ₹2,514 Cr | ₹1,520 Cr | ₹1,641 Cr | ₹1,831 Cr |
What is the latest Total Current Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹2,687 Cr |
| Mar2025 | ₹2,514 Cr |
| Mar2024 | ₹1,520 Cr |
| Mar2023 | ₹1,641 Cr |
| Mar2022 | ₹1,831 Cr |
How is Total Current Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,687 Cr | 6.86 | |
| Mar2025 | ₹2,514 Cr | 65.38 | |
| Mar2024 | ₹1,520 Cr | -7.35 | |
| Mar2023 | ₹1,641 Cr | -10.37 | |
| Mar2022 | ₹1,831 Cr | - | |
Compare Total Current Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,226.4 Cr | -0.6% | 10.7% | -13.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -0.6% |
10.7% |
-13.9% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses